TNF and tropical spastic paraparesis: Thus, commonly used TNF inhibitors such as Infliximab, Etanercept, Adalimumab, Certolizumab pegol or Golimumab might be repurposed for the treatment of iHAM and HAM patients, in agreement with our previous findings of TNF as a negative predictor of corticosteroid response in HAM patients (13).